Consequently, at some point during an on-going in vivo infection, PIV5 will undoubtedly encounter and infect cells that are already in an IFN-induced antiviral state and the way in which PIV5 (and other viruses) interacts with such cells is likely to influence its pathogenesis and epidemiology. This evidence concerns the gene IFNA1 and infection.